Catalyst Biosciences Inc trading halted, volatility trading pause
PremiumThe FlyCatalyst Biosciences Inc trading halted, volatility trading pause
3M ago
Gyre Therapeutics Seeks Compliance Amid Board Reshuffle
Premium
Company Announcements
Gyre Therapeutics Seeks Compliance Amid Board Reshuffle
4M ago
NMPA approves Gyre’s avatrombopag maleate tablets for TP associated with CLD
Premium
The Fly
NMPA approves Gyre’s avatrombopag maleate tablets for TP associated with CLD
5M ago
Gyre Therapeutics files to sell 1.08M shares of common stock for holders
PremiumThe FlyGyre Therapeutics files to sell 1.08M shares of common stock for holders
6M ago
Catalyst Biosciences Inc trading resumes
Premium
The Fly
Catalyst Biosciences Inc trading resumes
6M ago
Catalyst Biosciences Inc trading halted, volatility trading pause
Premium
The Fly
Catalyst Biosciences Inc trading halted, volatility trading pause
6M ago
Gyre Therapeutics: Annual Financial Results and Future Outlook
PremiumCompany AnnouncementsGyre Therapeutics: Annual Financial Results and Future Outlook
9M ago
Gyre Therapeutics presents poster on hydronidone at AASLD Meeting
Premium
The Fly
Gyre Therapeutics presents poster on hydronidone at AASLD Meeting
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100